Skip to Content

Proteonomix Inc PROT

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PROT is trading at a 389% premium.
Price
$0.00
Fair Value
$9.29
Uncertainty
Extreme
1-Star Price
$8.99
5-Star Price
Economic Moat
Rzgpp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PROT is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$7.91
Volume/Avg
803 / 868

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company focuses on developing therapeutics based upon the use of human cells and their derivative.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
2

Valuation

Metric
PROT
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PROT
Quick Ratio
0.38
Current Ratio
0.44
Interest Coverage
−8.05
Quick Ratio
No chart available

Profitability

Metric
PROT
Return on Assets (Normalized)
−13.89%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−43.48%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
ZygbdgbjZxmhs$598.1 Bil
Vertex Pharmaceuticals Inc
VRTX
LsmrcbzGrcsyg$126.0 Bil
Regeneron Pharmaceuticals Inc
REGN
KbtzrvsZwxmqvc$119.6 Bil
Moderna Inc
MRNA
PmqpxxdhJcmbh$47.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
NkkcqklvPrrvws$30.4 Bil
argenx SE ADR
ARGX
MhbzsytGmkw$27.4 Bil
BioNTech SE ADR
BNTX
NvscwskfJlyzk$20.8 Bil
Biomarin Pharmaceutical Inc
BMRN
NwrqzrwGytsgq$16.1 Bil
United Therapeutics Corp
UTHR
LxfhtfhJwdn$14.7 Bil
Incyte Corp
INCY
BvxcgtthzLglhtv$12.9 Bil

Sponsor Center